Miguel A. Sanfiel-Brito

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Increased Glycation Ratio and Risk of Complications in Latent Autoimmune Diabetes in Adults Compared With Type 1 Diabetes Onset before 30 Years: A Cohort Study.

Increased Glycation Ratio and Risk of Complications in Latent Autoimmune Diabetes in Adults Compared With Type 1 Diabetes Onset before 30 Years: A Cohort Study.

Journal: Diabetes technology & therapeutics

Published: May 29, 2026

Natural Language Processing of Unstructured Healthcare Data for Predicting Heart Failure in Individuals with Type 2 Diabetes.

Natural Language Processing of Unstructured Healthcare Data for Predicting Heart Failure in Individuals with Type 2 Diabetes.

Journal: Journal of clinical medicine

Published: March 12, 2026

Epigenetic alterations in type 1 diabetes and their association with poor glycemic control: the SED1-EPI substudy.

Epigenetic alterations in type 1 diabetes and their association with poor glycemic control: the SED1-EPI substudy.

Journal: Scientific reports

Published: August 26, 2025

Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data.

Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data.

Journal: Kidney diseases (Basel, Switzerland)

Published: December 20, 2024

Characterizing the clinical profile and prevalence of people with diabetes attended in the hospital setting by using unstructured healthcare data and natural language processing: the Diabetic@ study.

Characterizing the clinical profile and prevalence of people with diabetes attended in the hospital setting by using unstructured healthcare data and natural language processing: the Diabetic@ study.

Journal: Diabetes research and clinical practice

Published: August 20, 2024

Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study.

Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study.

Journal: Diabetes & metabolism

Published: September 26, 2023

Glucometrics knowledge and its relationship to glycemic control in people living with type 1 diabetes: The GluKometrics study.

Glucometrics knowledge and its relationship to glycemic control in people living with type 1 diabetes: The GluKometrics study.

Journal: Diabetes & metabolism

Published: September 11, 2023

Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study.

Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study.

Journal: Journal of clinical medicine

Published: May 14, 2023

Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-Wecan Study.

Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-Wecan Study.

Journal: Journal of clinical medicine

Published: July 25, 2022

Real-World Clinical Outcomes Associated with Canagliflozin in Patients with Type 2 Diabetes Mellitus in Spain: The Real-Wecan Study.

Real-World Clinical Outcomes Associated with Canagliflozin in Patients with Type 2 Diabetes Mellitus in Spain: The Real-Wecan Study.

Journal: Journal of clinical medicine

Published: June 13, 2020

Erratum to: Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes.

Erratum to: Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: August 25, 2017

Real-world clinical outcomes and predictors of glycaemic and weight response to exenatide once weekly in patients with type 2 diabetes: The CIBELES project.

Real-world clinical outcomes and predictors of glycaemic and weight response to exenatide once weekly in patients with type 2 diabetes: The CIBELES project.

Journal: International journal of clinical practice

Published: August 08, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026